Correction to: As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Works matching IS 00126667 AND DT 2019 AND VI 79 AND IP 16
Results: 11
1
2
Correction to: Polatuzumab Vedotin: First Global Approval.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
3
Darolutamide: First Approval.
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1813, doi. 10.1007/s40265-019-01212-y
- By:
- Publication type:
- Article
4
Upadacitinib: First Approval.
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1819, doi. 10.1007/s40265-019-01211-z
- By:
- Publication type:
- Article
5
Pexidartinib: First Approval.
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1805, doi. 10.1007/s40265-019-01210-0
- By:
- Publication type:
- Article
6
Pretomanid: First Approval.
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1797, doi. 10.1007/s40265-019-01207-9
- By:
- Publication type:
- Article
7
Lanadelumab: A Review in Hereditary Angioedema.
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1777, doi. 10.1007/s40265-019-01206-w
- By:
- Publication type:
- Article
8
Stiripentol: A Review in Dravet Syndrome.
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1785, doi. 10.1007/s40265-019-01204-y
- By:
- Publication type:
- Article
9
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects.
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1741, doi. 10.1007/s40265-019-01192-z
- By:
- Publication type:
- Article
10
As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1729, doi. 10.1007/s40265-019-01202-0
- By:
- Publication type:
- Article
11
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease.
- Published in:
- Drugs, 2019, v. 79, n. 16, p. 1757, doi. 10.1007/s40265-019-01198-7
- By:
- Publication type:
- Article